OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
VITA.MKE56

Vitaminka AD Prilep

Food ProcessingVerified

Vitaminka AD Prilep has a debt-to-equity ratio of 1.44, indicating a moderate reliance on debt financing, and a current ratio of 1.3, suggesting limited short-term liquidity cushion. The company's free cash flow is negative at -190.9 million MKD, and capital expenditures are -370.8 million MKD, indicating significant reinvestment in operations. The company's return on equity is 0.81%, and return on assets is 0.25%, both of which are below the typical thresholds for healthy profitability in the food processing industry. These metrics suggest that the company is not generating strong returns relative to its equity or asset base. Vitaminka AD Prilep operates in a diversified product portfolio, including snack products, instant beverages, and food additives. However, the financial data does not provide a breakdown of revenue by segment or geography, making it difficult to assess concentration risk or regional performance. The company's revenue for the latest period is 4.61 billion MKD. While the outlook for the current fiscal year is not explicitly provided, the negative free cash flow and high capital expenditures suggest a challenging growth environment. The company's operating income of 59.8 million MKD and net income of 9.9 million MKD indicate modest profitability. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's net cash is negative after subtracting total debt, which could constrain its ability to fund operations or invest in growth without external financing. The dilution risk is low, and no significant dilution sources are identified in the provided data. Recent events and filings are not detailed in the provided data, so no specific recent developments can be cited. The company's financial statements and disclosures are the primary sources of information for the current analysis.

30-day price · VITA.MKE-1.00 (-0.0%)
Low$12501.00High$12502.00Close$12501.00As of25 May, 00:00 UTC
Profile
CompanyVitaminka AD Prilep
TickerVITA.MKE
SectorConsumer Non-Cyclicals
BusinessFood & Beverages
Industry groupFood & Beverages
IndustryFood Processing
AI analysis

Business. Vitaminka AD Prilep is a Macedonia-based company engaged in the food processing industry, producing a wide range of snack products, beverages, and food additives, including its own brands Safari, Samba, and Cevitana.

Classification. Vitaminka AD Prilep is classified under the Consumer Non-Cyclicals economic sector, Food & Beverages business sector, and Food Processing industry, with a classification confidence of 0.92.

Vitaminka AD Prilep has a debt-to-equity ratio of 1.44, indicating a moderate reliance on debt financing, and a current ratio of 1.3, suggesting limited short-term liquidity cushion. The company's free cash flow is negative at -190.9 million MKD, and capital expenditures are -370.8 million MKD, indicating significant reinvestment in operations. The company's return on equity is 0.81%, and return on assets is 0.25%, both of which are below the typical thresholds for healthy profitability in the food processing industry. These metrics suggest that the company is not generating strong returns relative to its equity or asset base. Vitaminka AD Prilep operates in a diversified product portfolio, including snack products, instant beverages, and food additives. However, the financial data does not provide a breakdown of revenue by segment or geography, making it difficult to assess concentration risk or regional performance. The company's revenue for the latest period is 4.61 billion MKD. While the outlook for the current fiscal year is not explicitly provided, the negative free cash flow and high capital expenditures suggest a challenging growth environment. The company's operating income of 59.8 million MKD and net income of 9.9 million MKD indicate modest profitability. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's net cash is negative after subtracting total debt, which could constrain its ability to fund operations or invest in growth without external financing. The dilution risk is low, and no significant dilution sources are identified in the provided data. Recent events and filings are not detailed in the provided data, so no specific recent developments can be cited. The company's financial statements and disclosures are the primary sources of information for the current analysis.
Key takeaways
  • Vitaminka AD Prilep has a moderate debt load and limited short-term liquidity.
  • The company's profitability metrics are weak, with low return on equity and return on assets.
  • The company's product portfolio is diverse, but revenue concentration by segment or geography is not disclosed.
  • The company is facing a challenging financial environment, with negative free cash flow and high capital expenditures.
  • The risk assessment indicates a medium liquidity risk and a low dilution risk.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyMKD
Revenue$4.61B
Gross profit$1.18B
Operating income$59.8M
Net income$9.9M
R&D
SG&A
D&A
SBC
Operating cash flow$88.7M
CapEx-$370.8M
Free cash flow-$190.9M
Total assets$4.01B
Total liabilities$2.78B
Total equity$1.23B
Cash & equivalents$31.2M
Long-term debt$1.78B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.23B
Net cash-$1.75B
Current ratio1.3
Debt/Equity1.4
ROA0.2%
ROE0.8%
Cash conversion8.9%
CapEx/Revenue-8.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food Processing · cohort 6 companies
MetricVITA.MKEActivity
Op margin1.3%3.3% medp25 2.5% · p75 4.5%bottom quartile
Net margin0.2%3.0% medp25 1.5% · p75 6.7%bottom quartile
Gross margin25.5%24.0% medp25 20.2% · p75 35.3%above median
R&D / revenue0.8% medp25 0.5% · p75 2.3%
CapEx / revenue-8.0%5.2% medp25 4.8% · p75 5.7%bottom quartile
Debt / equity144.0%33.5% medp25 29.1% · p75 81.5%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 09:28 UTC#9ef8f833
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 09:29 UTCJob: 434a209e